金達威(002626.SZ):已根據協議約定向豐原藥業支付股權轉讓款1億元
格隆匯 12 月 8日丨金達威(002626.SZ)公佈,公司於2020年12月1日召開了第七屆董事會第十五次會議,審議通過了《關於購買江蘇誠信藥業有限公司86%股權的議案》。同意公司與自然人喻紅忠、卞雨花簽署了《關於江蘇誠信藥業有限公司之投資協議》,與安徽豐原藥業股份有限公司(“豐原藥業”)、南京冠準投資合夥企業(有限合夥)、自然人喻豔簽署《關於江蘇誠信藥業有限公司之股權轉讓協議》,以自有資金3.073億元購買上述出讓方所持有的江蘇誠信藥業有限公司(“誠信藥業”)相應股權。
近日,公司已根據協議約定向豐原藥業支付股權轉讓款1億元。誠信藥業收到啟東市行政審批局下發的《公司准予變更登記通知書》,豐原藥業已根據約定完成其持有誠信藥業28.41%股權交割、登記過户等相關工作;同時,自然人喻紅忠、卞雨花、喻豔均已根據協議約定分別完成了各自持有的誠信藥業32.95%、5.37%、1.37%的股權過户事宜。
此外,公司已收到啟東市行政審批局下發的《股權出質設立登記通知書》,喻紅忠已根據協議約定將其持有的誠信藥業剩餘10%的股權質押予公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.